Prognostic factors of liver metastases in extensive-stage small cell lung cancer receiving chemo-immunotherapy
Liver metastasis is a significant predictor of outcomes after chemoimmunotherapy in patients with ES-SCLC. The maximal diameter and number of liver metastases may affect the immune response in patients with liver metastasis.
Authors
- Hiroshi Kagamu (ORCID: https://orcid.org/0000-0003-4523-8517)
- Ayako Shiono (ORCID: https://orcid.org/0000-0001-6546-3864)
- Yuhei Kurata
- Kyoichi Kaira (ORCID: https://orcid.org/0000-0001-5548-7686)
- Kosuke Hashimoto (ORCID: https://orcid.org/0000-0003-3031-0635)
- Ou Yamaguchi (ORCID: https://orcid.org/0000-0001-7194-6459)
- Atsuto Mouri (ORCID: https://orcid.org/0000-0001-8704-8151)
- Yu Miura (ORCID: https://orcid.org/0000-0002-2752-5873)
- Hisao Imai
Institutions
- Saitama International Medical Center (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2025-05-01
- DOI
- https://doi.org/10.21037/tlcr-2024-1091
- Citations
- 6
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.27